Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Case Report

RMJ. 2016; 41(2): 262-264


Victoza for weight management - implications for use in Pakistan

Haider Ghazanfar, Sana Haq, Aliya Khurram, Syed Wajih Rizvi.

Abstract
We report a case of 33 year old diabetic female with morbid obesity (BMI 45.2 kg/m2). She was started on Victoza on a dose of 0.6 mg for first week, 1.2 mg for the second week and 1.8 mg from third week onwards, subcutaneously. Over the course of 9 months, she lost a total weight of 39 pounds (15.6% of her original body weight) without developing any serious side effects. Victoza is a safe and effective medication for weight loss and glycemic control and can play an integral part in weight management of diabetic patients.

Key words: Diabetes mellitus, obesity, weight loss, liraglutide



Similar Articles

The Evolution of Surgical Techniques and Biomaterials for Periodontal Regeneration.
Pagni G, Tavelli L, Rasperini G
Dental clinics of North America. 2022; 66(1): 75-85

Structural analysis and anti-cancer activity of low-molecular-weight chondroitin sulfate from hybrid sturgeon cartilage.
Wu R, Li P, Wang Y, Su N, Xiao M, Li X, Shang N
Carbohydrate polymers. 2022; 275(): 118700

Hyperglycemia in acute ischemic stroke: physiopathological and therapeutic complexity.
Ferrari F, Moretti A, Villa RF
Neural regeneration research. 2022; 17(2): 292-299

Assessment of structural brain changes in patients with type 2 diabetes mellitus using the MRI-based brain atrophy and lesion index.
Zhao H, Wang F, Luo GH, Lei H, Peng F, Ren QP, Chen W, Wu YF, Yin LC, Liu JC, Pan SN
Neural regeneration research. 2022; 17(3): 618-624

The Importance of Experimental Investigation of the Peripheral Oxytocin System.
Assinder SJ
Methods in molecular biology (Clifton, N.J.). 2022; 2384(): 1-27


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites